Show simple item record

The REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studies

dc.contributor.authorCampbell, Jonathan D
dc.contributor.authorPerry, Robert
dc.contributor.authorPapadopoulos, Nikolaos G
dc.contributor.authorKrishnan, Jerry
dc.contributor.authorBrusselle, Guy
dc.contributor.authorChisholm, Alison
dc.contributor.authorBjermer, Leif
dc.contributor.authorThomas, Michael
dc.contributor.authorvan Ganse, Eric
dc.contributor.authorvan den Berge, Maarten
dc.contributor.authorQuint, Jennifer
dc.contributor.authorPrice, David
dc.contributor.authorRoche, Nicolas
dc.date.accessioned2019-05-17T10:50:06Z
dc.date.available2019-05-17T10:50:06Z
dc.date.issued2019-03-27
dc.identifier.citationCampbell , J D , Perry , R , Papadopoulos , N G , Krishnan , J , Brusselle , G , Chisholm , A , Bjermer , L , Thomas , M , van Ganse , E , van den Berge , M , Quint , J , Price , D & Roche , N 2019 , ' The REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studies ' , Clinical and Translational Allergy , vol. 9 , no. 21 , 21 . https://doi.org/10.1186/s13601-019-0256-9en
dc.identifier.issn2045-7022
dc.identifier.otherPURE: 143973977
dc.identifier.otherPURE UUID: b69aebef-ea94-48e4-a497-b2e95919c032
dc.identifier.otherPubMed: 30962876
dc.identifier.otherPubMedCentral: PMC6436213
dc.identifier.otherScopus: 85063421513
dc.identifier.otherWOS: 000462588600002
dc.identifier.otherMendeley: ebe97ddc-461c-37f1-bef8-a5086a597d3b
dc.identifier.urihttp://hdl.handle.net/2164/12279
dc.identifier.urihttp://www.scopus.com/inward/record.url?scp=85063421513&partnerID=8YFLogxKen
dc.identifier.urihttp://www.mendeley.com/research/real-life-evidence-assessment-tool-relevant-development-novel-quality-assurance-asset-rate-observatien
dc.descriptionFunding for this research was provided by: European Academy of Allergy and Clinical Immunologyen
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofClinical and Translational Allergyen
dc.subjectAsthmaen
dc.subjectComparative effectiveness research (CER)en
dc.subjectQualityen
dc.subjectObservational studiesen
dc.subjectAssessment toolen
dc.subjectRELEVANTen
dc.subjectBECLOMETASONEen
dc.subjectPOPULATIONen
dc.subjectDATABASEen
dc.subjectASTHMAen
dc.subjectWORLD RESEARCHen
dc.subjectR Medicine (General)en
dc.subjectPulmonary and Respiratory Medicineen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.subjectSupplementary Dataen
dc.subject.lccR1en
dc.titleThe REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studiesen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s13601-019-0256-9
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85063421513&partnerID=8YFLogxKen
dc.identifier.urlhttp://www.mendeley.com/research/real-life-evidence-assessment-tool-relevant-development-novel-quality-assurance-asset-rate-observatien
dc.identifier.vol9en
dc.identifier.iss21en


Files in this item

Thumbnail
Name:
The_REal_Life_EVidence_Assessm ...
Size:
880.0Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record